[Baricitinib in the treatment of SARS-CoV-2 infection].

Gutiérrez-Lorenzo, MCuadros-Martínez, C M2023-02-092023-02-092020-06-25http://hdl.handle.net/10668/15821esBaricitinibSARS-COV-2hospitalinfectiontreatmentAzetidinesBetacoronavirusCOVID-19Coronavirus InfectionsHumansPandemicsPilot ProjectsPneumonia, ViralPurinesPyrazolesSARS-CoV-2Sulfonamides[Baricitinib in the treatment of SARS-CoV-2 infection].Baricitinib en el tratamiento de infección por SARS-CoV-2.research article32583654open access10.37201/req/047.20201988-9518PMC7374029https://seq.es/wp-content/uploads/2020/06/gutierrez25jun2020.pdfhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7374029/pdf